Literature DB >> 6781007

The effect of benztropine mesylate on the prolactin response to haloperidol.

U Halbreich, E J Sachar, R S Nathan, G M Asnis, F S Halpern.   

Abstract

The interaction between cholinergic and dopaminergic systems in regulating prolactin responses was investigated in normal men by administration of haloperidol (0.5 mg IM), with and without benztropine (1.0 and 2.0 mg IM). The acute prolactin response (at 30, 45, and 60 min) to haloperidol plus benztropine was significantly delayed compared to the response to haloperidol alone, in the same subjects. However, between 90 and 120 min after drug administration, prolactin responses achieved were similar in the three drug conditions. The results suggest a modest cholinergic-dopaminergic antagonism in the tuberoinfundibular system, apparent at low doses of neuroleptic and high doses of anticholinergic drugs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6781007     DOI: 10.1007/BF00433807

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Drug induced parkinsonism. A re-evaluation.

Authors:  W E Fann; C R Lake; B W Richman
Journal:  Dis Nerv Syst       Date:  1975-02

2.  Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency.

Authors:  G Langer; E J Sachar; P H Gruen; F S Halpern
Journal:  Nature       Date:  1977-04-14       Impact factor: 49.962

Review 3.  Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?

Authors:  S Matthysse
Journal:  Fed Proc       Date:  1973-02

4.  The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs.

Authors:  S H Snyder; K M Taylor; J T Coyle; J L Meyerhoff
Journal:  Am J Psychiatry       Date:  1970-08       Impact factor: 18.112

5.  Tubero-infundibular dopamine neurons and the secretion of luteinizing hormone and prolactin: extrahypothalamic influences, interaction with cholinergic systems and the effect of urethane anesthesia.

Authors:  W Lichtensteiger; P J Keller
Journal:  Brain Res       Date:  1974-07-12       Impact factor: 3.252

6.  Inhibition of prolactin secretion by cholinergic drug.

Authors:  L Grandison; M Gelato; J Meites
Journal:  Proc Soc Exp Biol Med       Date:  1974-04

7.  Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients.

Authors:  T E Hanlon; C Schoenrich; W Freinek; I Turek; A A Kurland
Journal:  Psychopharmacologia       Date:  1966

8.  Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action.

Authors:  J T Coyle; S H Snyder
Journal:  Science       Date:  1969-11-14       Impact factor: 47.728

9.  Influence of cholinergic receptor blockade on drug-induced prolactin release in the monkey.

Authors:  R R Gala; M G Subramanian; J A Peters; S Jaques
Journal:  Horm Res       Date:  1976

10.  Effect of antiparkinsonian medication on plasma levels of chlorpromazine.

Authors:  G M Simpson; T B Cooper; N Bark; I Sud; J H Lee
Journal:  Arch Gen Psychiatry       Date:  1980-02
View more
  2 in total

1.  Interaction study between remoxipride and biperiden.

Authors:  W Yisak; L Farde; C von Bahr; L B Nilsson; G Fredriksson; S Ogenstad
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  Effects of 4 weeks treatment with chlorpromazine and/or trihexyphenidyl on the pituitary-gonadal axis in male paranoid schizophrenics.

Authors:  P Rinieris; J Hatzimanolis; M Markianos; C Stefanis
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.